MDL2503: In Re: Solodyn (Minocycline Hydrochloride) Antitrust Litigation


Case Information Counsel List Orders/Opinions Procedures
Upcoming Proceedings Pacer Dockets Court Contacts


Case Information

MDL 2503: In Re: Solodyn (Minocycline Hydrochloride) Antitrust Litigation

LEAD CASE NUMBER 1:13-md-2503

These actions are purported nationwide class actions alleging that defendant violated federal and state antitrust laws by excluding generic competition for Solodyn through, among other things: filing sham patent litigation and baseless citizen petitions with the Food and Drug Administration, entering into reverse payment agreements in which Medicis allegedly agreed to pay the generic manufacturer defendants substantial sums in exchange for delaying entry of their less expensive generic versions of Solodyn into the market, and enacting a "product-hopping" scheme in which Medicis unneccessarily introduced varying dosages of Solodyn in an effort to deplete demand for approved generic dosages. These cases have been assigned to Judge Denise J. Casper.

To view the docket entries, they can click here.

To view the Liason Counsel information, they can click here.

To view the Opinions, they can click here.


text size  
Home      Boston      Springfield      Worcester      Mission Statement      Careers      Pro Se Litigants      Records Search      Site Map